Once-Daily Anticoagulant Xarelto Approved By FDA For DVT Prevention
Blood thinner (anticoagulant) Xarelto (rivaroxaban tablets) has been approved by the FDA (Food and Drug Administration) for the prevention of DVT (deep vein thrombosis) in patients who had knee or hip replacement surgery. The tablets are taken once daily. According to Xarelto makers, Janssen Pharmaceuticals, Inc., about 80,000 patients in the USA undergo hip or knee replacement surgery every year, the majority of them are aged 50+ years and suffer from arthritis. They have a significantly higher risk of DVT...
Once-Daily Anticoagulant Xarelto Approved By FDA For DVT Prevention
Linear Mode
